Israeli study finds Pfizer Covid-19 booster protects against Omicron


JERUSALEM (Reuters): Israeli researchers said on Saturday (Dec 11) that they found that a three-shot course of the Pfizer / BioNTech Covid-19 vaccine provided significant protection against the new Omicron variant.

The findings were similar to those presented by BioNTech and Pfizer earlier in the week, which were an early signal that booster shots could be key to protect against infection from the newly identified variant.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!
Covid-19 , Study , Pfizer , BioNTech , Vaccine

Next In World

Supreme Court lets Trump end deportation protections for Syrians and Haitians
US Supreme Court sides with Trump in asylum-processing case
Danish police find no proof drones caused Copenhagen Airport shutdown
Afghanistan's Taliban government imposes smartphone ban on government officials
Russia denies pressuring Belarus to widen Ukraine conflict; Minsk blames West
Rural area in Northern California jolted by its biggest quake since 1940
Brazilian right courts crime-weary voters with 'Bukele model' crackdown
Russia hits Ukrainian locomotives and fuel stations, leaving one dead
Analysis-Poland and Ukraine's difficult history creates political minefield for Tusk
Not cool at school: Europe’s classrooms struggle with the heat

Others Also Read